Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis.
Ursodeoxycholic acid suppresses the malignant progression of colorectal cancer through TGR5-YAP axis.
复制标题
熊去氧胆酸通过TGR5-YAP轴抑制结直肠癌恶性进展
DOI:
10.1038/s41420-021-00589-8
复制
发表时间:
2021-08-07
影响因子:
7
通讯作者:
Bi F
中科院分区:
文献类型:
--
作者:
Zhang H;Xu H;Zhang C;Tang Q;Bi F
The Hippo/YAP pathway plays an important role in the development of cancers. Previous studies have reported that bile acids can activate YAP (Yes Associated Protein) to promote tumorigenesis and tumor progression. Ursodeoxycholic acid (UDCA) is a long-established old drug used for cholestasis treatment. So far, the effect of UDCA on YAP signaling in colorectal cancer (CRC) is not well defined. This study means to explore relationship of UDCA and YAP in CRC. UDCA suppressed YAP signaling by activating the membrane G-protein-coupled bile acid receptor (TGR5). TGR5 mainly regulated cAMP/PKA signaling pathway to inhibit RhoA activity, thereby suppressing YAP signaling. Moreover, the restoration of YAP expression alleviated the inhibitory effect of UDCA on CRC cell proliferation. In AOM/DSS-induced CRC model, UDCA inhibited tumor growth in a concentration-dependent manner and decreased expression of YAP and Ki67. UDCA plays a distinguished role in regulating YAP signaling and CRC growth from the primary bile acids and partial secondary bile acids, demonstrating the importance of maintaining normal intestinal bile acid metabolism in cancer patients. It also presents a potential therapeutic intervention for CRC.
登录
查看更多内容
影响因子:
9.7
作者:
Im, E;Choi, SH;Kim, ND
通讯作者:
Kim, ND
影响因子:
9.7
作者:
Im, EO;Choi, YH;Kim, ND
通讯作者:
Kim, ND
影响因子:
4.7
作者:
Oyama, K;Shiota, G;Kawasaki, H
通讯作者:
Kawasaki, H
影响因子:
16.6
作者:
Oakes PW;Wagner E;Brand CA;Probst D;Linke M;Schwarz US;Glotzer M;Gardel ML
通讯作者:
Gardel ML
DOI:
10.1016/bs.pmbts.2015.02.005
发表时间:
2015
影响因子:
--
作者:
Kennedy JE;Marchese A
通讯作者:
Marchese A